model [8] . Apoptosis also plays a central role [9] . More recently, we demonstrated an up-regulated expression  2002 by the International Society of Nephrology of VEGF mRNA and protein along with an increased (4) CsA ϩ HH: Rats received a daily SC injection of CsA 15 mg/kg plus hydralazine 10 mg/kg/day and expression of Flt-1 and KDR/Flk-1 in this model [10] .
In the kidney, VEGF is constitutively expressed pri-hydrochlorthiazide (HCTZ) 10 mg/kg/day (both by matrix-driven delivery pellet). marily on glomerular visceral epithelial and tubular cells, but its function is not fully delineated [3] [4] [5] 11] . Flt-1 (5) CsA ϩ E: Rats received a daily SC injection of CsA 15 mg/kg, and enalapril 10 mg/kg by gavage. and KDR/Flk-1 are present not only on renal endothelial cells, but also on human mesangial and rat renal tubular (6) CsA ϩ L: Rats received a daily SC injection of CsA 15 mg/kg, and losartan 10 mg/kg by gavage. epithelial cells [3] [4] [5] 12] . VEGF plays a role in endothelial development, in enhancing endothelial cell permeability and in post-injury glomerular regeneration. Recently, an This dosage and route of administration for enalapril and losartan were selected because they were respectively increased VEGF expression was shown in renal biopsies from recipients with chronic rejection [13] . Of note is previously shown to significantly block ACE activity and AT 1 receptors [17] . that VEGF is increased in conditions associated with macrophage infiltration, and that both chronic renal allo-On day 7 or 28, systolic blood pressure was measured by tail plethysmography (Natsume Seisakusho Co. Ltd., graft rejection and chronic CsA nephrotoxicity show a heavy monocytic infiltration.
Tokyo, Japan) and 24-hour urine samples were collected in metabolic cages (Nalge Company, Rochester, NY, Angiotensin II plays an important role in pathological extracellular matrix (ECM) accumulation in models of USA). The following day, the rats were anesthetized with intraperitoneal ketamine, the abdomen was opened progressive glomerulosclerosis and interstitial fibrosis, independent of its effect on glomerular pressure [14] . On through a midline incision and the aorta was cannulated retrogradely below the renal arteries with an 18-gauge the other hand, angiotensin-converting enzyme (ACE) inhibitors and angiotensin II subtype 1 (AT 1 ) receptor needle. With the aorta occluded by ligation above the renal arteries and the renal veins opened by a small antagonists can reverse or attenuate fibrosis in a number of animal and human kidney diseases [15] . In kidney incision for outflow, the kidneys were perfused with 20 mL of cold heparinized saline. The left kidney was re-transplantation, several lines of evidence suggest a role for the renin-angiotensin system (RAS) in the develop-moved and processed for light microscopy and protein analysis. After removing the right kidney, the cortex was ment and progression of chronic allograft injury [16] . We have previously shown that Ang II blockade resulted dissected from the medulla, and the cortex was processed for RNA analysis. The animals were then euthanized by in the amelioration of CsA-induced fibrosis and in the decrease in the expression of TGF-␤1 and matrix pro-deep anesthesia with ketamine followed by exsanguination. teins [17] . These data, together with the recent findings that Ang II stimulates VEGF production [18], prompted Drugs us to investigate whether Ang II regulates the production of VEGF and the expression of receptors Flt-1 and KDR/ Cyclosporine A (Novartis Research Institute, East Hanover, NJ, USA) was diluted in olive oil to a final Flk-1 in a model of chronic CsA nephrotoxicity. concentration of 15 mg/mL. VH consisted of an identical volume of olive oil. Losartan (Du Pont Merck Pharma-METHODS ceutical, Wilmington, DE, USA) was dissolved in sterile Experimental design water and orally given to animals at 10 mg/kg/day. Enalapril (Merck, Rahway, NJ, USA) was diluted in sterile Thirty-two male Sprague-Dawley rats (Charles River, Wilmington, MA, USA) weighing 225 to 250 g were water and orally given to animals at 10 mg/kg/day. Nilvadipine (Fujisawa, Osaka, Japan) was diluted in etha-used. They were housed in individual cages in a temperature and light controlled environment, received a low nol/olive oil and subcutaneously given to animals at 0.5 mg/kg/day. Matrix-driven delivery pellet of hydralazine salt diet (0.05% sodium, Teklad Premier, WI, USA) and were allowed free-access to water. After one week on and hydrochlorthiazide (Innovative Research of America, Toledo, OH, USA) were subcutaneously implanted low salt diet, they were assigned to the following experimental groups (N ϭ 5 to 6/group) and were sacrificed in animals and released at 10 mg/kg/day, respectively. at 7 or 28 days.
Functional studies
Blood was collected from the jugular vein in plastic (1) Inc., Nutley, NJ, USA). Creatinine clearance (C Cr ) was 18 hours with cDNA probes labeled with 32 P-dCTP by random oligonucleotide priming (Boehringer Mann-calculated using a standard formula. CsA blood level was measured by a monoclonal radioimmunoassay for heim, Mannheim, Germany). Blots were washed in 2 ϫ SSC, 0.1% SDS at room temperature for 15 minutes, CsA (Incstar Co., Stillwater, MN, USA). and in 0.1 ϫ SSC, 0.1% SDS at 50ЊC for 15 minutes. Histology Films were exposed at Ϫ70ЊC for different time periods to ensure linearity of densitometric values and exposure Tissue was fixed in 10% buffered formalin and embedded in paraffin. Sections 2 to 4 thick were stained with time. Autoradiographs were scanned on an imaging densitometer (GS-700; Bio-Rad Laboratories, Hercules, periodic acid-Schiff (PAS) reagent and trichrome stain and examined by light microscopy. The histologic find-CA, USA). The density of bands for the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA was used ings were subdivided into two categories: interstitial fibrosis and arteriolopathy. The findings of interstitial fibro-to control for differences in the total amount of RNA loaded onto each gel line. Equal loading was further sis consisted of matrix-rich expansion of the interstitium with distortion and collapse of the tubules and thicken-ensured by the ethidium bromide gel inspection. For quantitative purposes, values were divided by the den-ing of the tubular basement membranes. Features of interstitial inflammation included mononuclear infiltrates, sity of bands for GAPDH in the same lane. The VEGF cDNA probe used was a 384 bp Not I-EcoRI murine edema and vacuolization of interstitial cells. Arteriolopathy consisted of hyalinization and destruction of afferent cDNA fragment of clone pT7T3D-Pac (American Type Culture Collection, Rockville, MD, USA). The rat arterioles and terminal portions of interlobular arteries. A minimum of 20 fields at ϫ100 magnification were as-GAPDH cDNA probe (plasmid pBluescript KS II) was a gift from J.M. Blanchard [19] . Flt-1 and KDR/Flk-1 sessed and graded in each biopsy by an observer masked to treatment groups using a color image analyzer (Nikon cDNA probes were derived from rat reverse transcription-polymerase chain reaction (RT-PCR) products. For E400, Nikon Inc., Tokyo, Japan; Pixera Professional digital camera, Los Gatos, CA, USA; Macintosh Powerbook Flt-1, both sense and antisense primers were located in the extracellular region: sense 5Ј-AGCCCACCTCTC G3, NIH Image v. 1.5). Interstitial fibrosis was estimated by counting the percentage of injured areas per field of TATCCGCTGG, antisense 5Ј-GGCGCTTCCGAATC TCTA. For KDR/Flk-1, the primers were sense 5Ј-AGC cortex and scored semiquantitatively using the following: 0 ϭ normal interstitium; 0.5 ϭ Ͻ5% of areas injured; TTGGCTCACAGGCAACATCGG (located in the sixth IgG-like domain), antisense 5Ј-TGGCCCCGCTTAAC 1 ϭ 5 to 15%; 1.5 ϭ 16 to 25%; 2 ϭ 26 to 35%; 2.5 ϭ 36 to 45%; and 3 ϭ Ͼ45%. Arteriolar hyalinosis was GGTCCGT (located between the transmembrane region and the intracellular domain). For RT-PCR, 5 g semiquantitatively assessed by counting the percentage of juxtaglomerular afferent arterioles available for exam-total RNA were combined with 2 L random primers (Gibco BRL) and 2 L of Moloney murine leukemia ination with a minimum of 100 glomeruli per biopsy assessed: 0 ϭ no arterioles injured; 0.5 ϭ Ͻ15%; 1 ϭ 15 virus (MMLV) reverse transcriptase per the manufacturer's instructions. RT product 1 to 2 L was amplified to 30%; 1.5 ϭ 31 to 45%; 2 ϭ 46 to 60%; 2.5 ϭ 61 to 75%; and 3 ϭ Ͼ75%.
using the Perkin-Elmer thermal cycler (Norwalk, CT, USA). Cycles used for PCR for both Flt-1 and KDR/
Northern blot analysis
Flk-1 were 94ЊC for five minutes (once), 94ЊC for one minute, 58ЊC for one minute, 72ЊC for one minute (30 Renal tissue was finely minced with a razor blade on ice then homogenized in TRIzol reagent (Gibco Brl, cycles), and 72ЊC for five minutes (once). PCR products were electrophoresed in 1% agarose gel and photo-Grand Island, NY, USA). RNA extraction was performed per the manufacturer's protocol. After resuspen-graphed under ultraviolet light. The cDNA probes obtained were sequenced and the correct sequences were sion in Tris-EDTA buffer, RNA concentrations were determined using spectrophotometric readings at Ab-confirmed. The PCR products were cloned using the Original TA Cloning kit (Invitrogen, Carlsbad, CA, sorbance 260 . RNA 30 g were electrophoresed in each lane in 0.9% agarose gels containing 2.2 mol/L formalde-USA) per the manufacturer's instructions. hyde and 0.2 mol/L Mops (pH 7.0) and transferred to a Western blot analysis nylon membrane (ICN Biomedicals, Costa Mesa, CA, USA) overnight by capillary blotting. Nucleic acids were Frozen (Ϫ70ЊC) kidney tissue sections embedded in Tissue-Tek O.C.T. (Miles Inc., Diagnostics Div., Elkhart, cross-linked by ultraviolet irradiation (Stratagene, La Jolla, CA, USA). The membranes were prehybridized IN, USA) were processed for protein extraction as previously described. Equal amounts of protein were re-for two hours at 42ЊC with 50% formamide, 10% Denhardt's solution, 0.1% sodium dodecyl sulfide (SDS), 5 ϫ solved on 15% SDS-PAGE gel (Bio-Rad) and then electroblotted to nitrocellulose membranes (Bio-Rad). After standard saline citrate (SSC), and 200 g/mL denatured salmon sperm DNA. They were hybridized at 42ЊC for blocking the membranes for one hour with TBS-T, they Table 1 . There were no significant All sections for VEGF staining were subjected to antidifferences in body weight or in the rate of weight gain gen retrieval using immersion in a 0.1 mol/L citrate buffer suggesting that food intake was comparable in all groups (pH 6.0), followed by heating in an electrical pressure (data not shown). CsA blood levels increased progrescooker for three minutes (total time 30 min). All steps sively and, at the end of each treatment period, similar were carried out at room temperature. The primary levels were achieved. CsA-induced hypertension was not VEGF antibody was applied overnight at a dilution of observed in this model. Despite that, addition of losartan 1:100. This was followed sequentially by incubation for or enalapril caused an early sustained and significant 30 minutes with a secondary anti-rabbit IgG antibody decrease in blood pressure (P Ͻ 0.05 at 7 and 28 days (Sigma, St. Louis, MO, USA) at a dilution of 1:300 and vs. CsA-only group). In order to control for the effect streptavidin peroxidase-conjugated (Dako, Carpenteria, of blood pressure on interstitial fibrosis, rats were ran-CA, USA), with color development using diaminobenzidomized to receive CsA ϩ N or CsA ϩ HH for 7 or 28 dine (DAB; Dako) for five minutes.
days with blood pressure reductions similar to the Immunostaining for macrophages was carried out us-CsA ϩ E and CsA ϩ L groups being achieved. All CsAing a slide autostainer (Ventana, Tucson, AZ, USA). treated animals had a significant increase in their serum All steps were performed at 37ЊC. Slides were pretreated creatinine by day 28 (P Ͻ 0.05 vs. VH group) and experiby Protease 2 enzyme digestion for 12 minutes. The enced a decline in their glomerular filtration rates as primary antibody (ED1) was applied at a dilution of estimated by creatinine clearance (C Cr ). This was present 1:800 for 32 minutes. This was followed by incubation by day 7 but became more significant at 28 days (P Ͻ for 8 minutes with a secondary anti-mouse IgG antibody 0.05 vs. VH group). Animals treated with CsA ϩ N or (Vector Labs, Burlingame, CA, USA) at a dilution of CsA ϩ HH had a significantly higher GFR compared 1:300. Detection steps were then performed using the to those treated with CsA ϩ E or CsA ϩ L (P Ͻ 0.05). basic DAB kit from Ventana.
There were no significant differences in C Cr between the
Statistical analysis
CsA only, CsA ϩ N and CsA ϩ HH groups. Results are presented as mean Ϯ standard error. Com-Histologic changes parisons between groups were done by analysis of vari-
The histologic changes observed are summarized in ance (ANOVA; the Kruskal-Wallis test followed by Tu- Table 2 . VH-treated rats demonstrated a normal kidney key test). The level of statistical significance was chosen histology (Fig. 1A, B ). By contrast, the kidneys of CsAas P Ͻ 0.05. treated rats developed a striped pattern of tubulointerstitial fibrosis and tubular atrophy (Fig. 1C ) in addition to RESULTS afferent arteriolar hyalinosis (Fig. 1D ). When the extent Physiologic studies of the histological changes was graded using a 0 to 3ϩ semiquantitative score, most of the differences were ob-Values for serum creatinine, creatinine clearance, systolic blood pressure, and CsA whole blood trough levels served at 28 days ( Table 2 ). The concurrent administra- The immunohistochemical staining for VEGF at 28 L, losartan. days is shown in Figure 5 and was mostly present in the a P Ͻ 0.05 vs. CsA only corticomedullary junction and in the outer medullary areas. CsA-treated rats exhibited a strong, diffuse and granular cytoplasmic staining for VEGF. This was mostly seen in the tubulointerstitium with strongly positive tion of losartan or enalapril with CsA dramatically and (more than 90%) staining in both proximal and distal equally improved the tubulointerstitial fibrosis (P Ͻ tubular epithelial cells. There was also positive staining 0.05) and the afferent arteriolopathy (P Ͻ 0.01) when of occasional glomerular podocytes. This was in sharp compared to the CsA-only treated group ( Fig. 1 E, F) .
contrast with VH-treated rats that showed only focal, On the other hand, CsA-induced tubulointerstitial fifaint and non-specific cytoplasmic staining for VEGF in brosis was not affected by the concurrent use of nilvaditubular epithelial cells. On the other hand, treatment of pine and worsened with the hydralazine-HCTZ combi-CsA rats with losartan reduced greatly the intensity of nation ( Table 2 ). Of note is that the beneficial effect of VEGF staining in tubular epithelial cells. In addition, Ang II blockade was more significant in preventing CsA-VEGF-positive cells colocalized in serial sections with induced arteriolopathy than in ameliorating the tubulothe ED1 marker for macrophages. interstitial fibrosis.
There was also a difference in the number of ED1-Expression of Flt-1 and KDR/Flk-1 receptors positive macrophages at 28 days (Fig. 2) . In the VH-
The mRNA expressions of the Flt-1 and KDR/Flk-1 treated rats, there were very few macrophages in the receptors were similar in the VH-treated groups and interstitium. However, CsA-treated kidneys displayed were lower than the levels observed in CsA only-treated large numbers of macrophages infiltrating the tubuloinkidneys (Figs. [6] [7] [8] . CsA treatment increased the mRNA terstitium. On the other hand, those animals treated with expression of Flt-1 and KDR/Flk-1 early at seven days CsA and losartan showed only rare macrophages. The (P Ͻ 0.01 vs. VH group); CsA increased KDR/Flk-1 number of macrophages identified in the glomeruli was expression to a greater extent than Flt-1. Flt-1 receptor not different between the three groups. became significantly down-regulated early (P Ͻ 0.05 vs. VH) in all the treated groups and its expression seemed VEGF expression to be independent of the antihypertensive agent used The mRNA expression of VEGF was clearly up-regu-(Figs. 6 and 8). Its expression remained low and unlated in the CsA-treated rats as compared to the VHchanged at 28 days and no specific effect was observed treated rats ( Figs. 3 and 8 ). This effect was seen early with Ang II blockade. On the other hand, the behavior of at 7 days (P Ͻ 0.05), and it progressively increased and the KDR/Flk-1 mRNA receptor was somewhat different continued to be significant in the CsA-treated kidneys ( Figs. 7 and 8) . It declined with time and was higher at at 28 days (P Ͻ 0.05). Ang II blockade with losartan or 7 days compared to 28 days possibly due to VEGF downenalapril equally decreased VEGF mRNA expression regulating its own receptor. There was a specific effect (P Ͻ 0.05) by approximately 40 to 50% at 7 days and observed with Ang II blockade where both enalapril by 22 to 24% at 28 days compared to the CsA only and losartan significantly decreased KDR/Flk-1 mRNA group. To assess whether the changes in the mRNA expression at both time points studied (P Ͻ 0.05 vs. VH expression were translated into changes in the synthesis group). However, a similar effect was not observed in of VEGF peptide, Western blots were performed on the CsA ϩ N and CsA ϩ HH groups where there was tissue homogenates derived from the whole cortex. The a trend toward a lower KDR/Flk-1 expression, but the protein expression of VEGF was similar to its mRNA difference did not achieve statistical significance. (Figs. 4 and 8) in that it increased at day 7 (P Ͻ 0.05) and more so at day 28 (P Ͻ 0.05) in CsA-treated rat DISCUSSION kidneys when compared to VH-treated rats. Similarly, Ang II blockade with losartan or enalapril equally and
We have previously shown that the expression of VEGF and its receptors Flt-1 and KDR/Flk-1 was up-significantly decreased VEGF peptide production (P Ͻ Fig. 1. Histologic changes. Photomicrographs showing the renal cortex of a salt-depleted rat given vehicle (VH; A, B) , cyclosporine A (CsA) 15 mg/kg/day (C, D), or a combination of CsA 15 mg/kg/day and losartan 10 mg/kg/day (E, F ). VH-treated rats display normal kidney histology (A, B) . In rats treated with CsA, extensive interstitial fibrosis and tubular atrophy (C) and afferent arteriolopathy (D) are seen. When both CsA and losartan are given in combination, these changes are markedly reduced (E, F). Trichrome (A, C, E), PAS (B, D, F). Original magnification ϫ200. the use of nilvadipine or with hydralazine/HCTZ failed to achieve similar results. In addition, the effects of ena-regulated in chronic CsA nephrotoxicity [10] . These changes were seen only in rats on low salt diet in which lapril and losartan on kidney histology and VEGF expression were comparable. nephrotoxicity developed and not in rats on normal salt diet that remained disease free. This led to the suggestion Previous reports have demonstrated that Ang II is a potent stimulus for VEGF in vascular smooth muscle, that CsA nephrotoxicity, and not merely CsA administration, is responsible for the enhanced VEGF expres-cardiac and retinal endothelial, and mesangial cells [21] [22] [23] [24] [25] [26] . This action is Ang II concentration-dependent sion. Since a low salt diet activates the RAS, we examined the effect of Ang II blockade on VEGF expression. and is rapid in onset [26] . Ang II exerts its multiple actions via specific receptors. To date, most of the recog-Our prior study showed that Ang II blockade ameliorated chronic CsA nephrotoxicity [17] . Our current study nized biological actions of Ang II are transduced via the AT 1 receptor [27]. In this model, the RAS is clearly shows a similar beneficial effect, namely a reduction in interstitial fibrosis and arteriolopathy. The protective ef-activated and the effects exerted by CsA on VEGF were abolished by losartan, suggesting the involvement of the fect of RAS blockade on the kidney was dissociated from its renal hemodynamic effects, since there was worsening AT 1 receptor. This is similar to other studies that showed that AT 1 receptor antagonists, but not AT 2 antagonists, of the GFR in the losartan and enalapril-treated rats, a finding similar to previous observations in the same model are capable of inhibiting completely the effect of Ang II on VEGF [28]. Our results do not necessarily contradict [17, 20] . Part of the beneficial effects of Ang II blockade also could have been related to its antihypertensive effect. recent findings that VEGF infusion improved CsA-associated hypertension in rats on a high-salt diet since, un-However, more interestingly, VEGF mRNA expression and peptide production were specifically and significantly like our model, the RAS in this setting was blunted [29] . Also, we did not investigate the mechanism through reduced by Ang II blockade. This effect was seen early, persisted at 28 days, and was independent of blood pres-which Ang II affected VEGF expression. It could be due to an inhibition in mRNA transcription and/or a decrease sure since a comparable decrease in blood pressure with in mRNA stability. In hypoxia, VEGF was increased in human epithelial cells through increasing mRNA tran-VEGF receptors expression. KDR/Flk-1 decreased in a scription and stability [30] . On the other hand, Ang II manner similar to VEGF, an effect not seen in the other was able to activate VEGF transcription in bovine retinal groups. On the other hand, the behavior of Flt-1 was pericytes without changing the mRNA half-life [25] . It independent of Ang II. Based on these findings, we conis interesting to note that the VEGF gene contains a clude that VEGF probably exerted its biological effect number of motifs in the 3Ј untranslated region involved in this model via KDR/Flk-1. It also is possible that in regulating mRNA stability [31] .
Ang II may directly regulate KDR/Flk-1 gene expres-There is convincing evidence in vitro and in vivo that sion. Recently, in a report investigating Ang II activity Ang II increases TGF-␤ [32] and that Ang II blockade in retinal endothelial cells, Ang II potentiated VEGFdecreases TGF-␤ [14] . Along those lines, we have shown induced angiogenic activity through KDR/Flk-1 but had that Ang II blockade decreases TGF-␤1 in chronic CsA no effect on Flt-1 [21]. These two receptors display differnephrotoxicity [17] . Since TGF-␤ induces VEGF in sevences in function; for example, KDR/Flk-1-expressing eral cell types [1, 3, 26] , it is conceivable that Ang IIcells show changes in morphology, chemotaxis, and mitoinduced VEGF could be mediated via Ang II-induced genicity upon VEGF stimulation, whereas Flt-1-expressrelease of TGF-␤. However, two lines of evidence negate ing cells lack such response [1, 32] . Also, gene knockout this possibility: (1) Ang II actions to increase VEGF experiments suggest differences in vascular development occur rapidly and earlier than the time course for TGF-␤ [1] . It is thought that Flt-1 is not a signal receptor, but induction by Ang II [18]; (2) the released TGF-␤1 is in rather a "decoy" receptor that negatively regulates the latent form by bioassays [22] . These observations do VEGF by sequestering it and rendering it less available not necessarily exclude the possibility that more proto KDR/Flk-1 [33]. However, subsequent studies indilonged Ang II stimulation, by allowing time for TGF-␤ cated that Flt-1 interacts with some signal transducing production, could increase VEGF directly via the AT 1 proteins [32, 34] . Nevertheless, most studies support the receptor and indirectly via TGF-␤.
We also investigated the effect of Ang II blockade on hypothesis that interaction with KDR/Flk-1 is a critical requirement to induce the full spectrum of VEGF biolog-know that VEGF is chemotactic for macrophages and is increased in conditions associated with macrophage ical responses. In support of this, VEGF mutants that bind selectively to KDR/Flk-1 are fully active endothelial infiltration. In human chronic rejection, VEGF-positive cells in the interstitium colocalized with macrophages cell mitogens and anti-idiotypic antibodies that activate KDR/Flk-1 promote tumor angiogenesis [35, 36] . In ad- [13] . It is also important to note that our CsA model displays a mononuclear infiltrate that precedes intersti-dition, it used to be believed that VEGF receptors were restricted to the endothelium and that VEGF exerts its tial fibrosis and that is improved by Ang II blockade [17] . In this experiment, the number of mononuclear activity in an autocrine fashion. However, recent findings confirmed the presence of VEGF receptors on nonendo-cells increased with CsA administration and later declined with losartan treatment. Moreover, VEGF expres-thelial cells and suggested that VEGF acts also in a paracrine fashion [37] . sion colocalized with that of ED-1 positive cells in serial sections. This suggests that either VEGF is produced by What effect VEGF actually has on chronic CsA nephrotoxicity remains unclear because the renal actions of macrophages or that it is contributing to their recruitment into the interstitium. Moreover, Ang II is known VEGF remain speculative. A study in patients with chronic renal disease noted an up-regulated VEGF ex-to play a role in the progression of glomerular and tubulointerstitial fibrosis [41] . Thus, it is possible that Ang II pression in the interstitium, but the signals were reduced in globally sclerosed glomeruli [38] . These results are blockade, by decreasing VEGF, is capable of decreasing monocytic attraction, thereby aborting a self-perpetuat-consistent with a temporal sequence in which VEGF expression precedes renal fibrosis and is then down-regu-ing loop of myofibroblast proliferation and interstitial fibrosis. lated or disrupted after fibrosis. Further studies are needed to determine whether VEGF is in fact a signaling
The results reported herein raise some intriguing questions. Since VEGF is a potent endothelial cell mitogen, molecule involved in enhancing glomerular sclerosis or interstitial fibrosis. More recently, VEGF was shown to it is possible that Ang II-induced VEGF production is a compensatory mechanism directed at replacing the activate MAP kinase and to enhance collagen synthesis in human mesangial cells [39] . Of interest, VEGF also damaged endothelium caused by CsA. In addition, it is possible that VEGF plays a role, either independently was reported to induce interstitial collagenase in endothelial cells but not in fibroblasts [40] . Thus, both matrix or through Ang II, in CsA-induced fibrosis. This may be related either directly through its effect on matrix synthesis and degradation may be regulated by VEGF through contrasting actions on renal cells. Moreover, we remodeling or indirectly through its chemotactic effect 
